Windtree Therapeutics, Inc. (WINT) Reports Q4 Loss of $0.77

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to Windtree Therapeutics, Inc. (WINT) Reports Q4 Loss of $0.77

Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates

March 31, 2017 7:30 AM EDT

WARRINGTON, Pa., March 31, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (Nasdaq: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported financial results for the fourth quarter ended December 31, 2016 and provided key business updates. 

Key Business and Financial Updates

Enrollment in the AEROSURF® phase 2b clinical trial in up to 240 premature infants 28 to 32 week gestational age for respiratory distress syndrome (RDS) is progressing and the Company reaffirms its... More